ArticleJournal for immunotherapy of cancer2024

MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors.

Si Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.